Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
Kushwah, R., and Hu, J. (2010). Dendritic cell apoptosis: regulation of tolerance versus
immunity. J Immunol 185, 795-802.
Kuwajima, S., Sato, T., Ishida, K., Tada, H., Tezuka, H., and Ohteki, T. (2006). Interleukin
15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for
CpG-induced immune activation. Nat Immunol 7, 740-746.
Lahoud, M.H., Ahmet, F., Kitsoulis, S., Wan, S.S., Vremec, D., Lee, C.N., Phipson, B., Shi,
W., Smyth, G.K., Lew, A.M., et al. (2011). Targeting antigen to mouse dendritic cells via
Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. J
Immunol 187, 842-850.
Le Bon, A., Durand, V., Kamphuis, E., Thompson, C., Bulfone-Paus, S., Rossmann, C.,
Kalinke, U., and Tough, D.F. (2006). Direct stimulation of T cells by type I IFN enhances the
CD8+ T cell response during cross-priming. J Immunol 176, 4682-4689.
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., and
Tough, D.F. (2003). Cross-priming of CD8+ T cells stimulated by virus-induced type I
interferon. Nat Immunol 4, 1009-1015.
Lennon-Dumenil, A.M., Bakker, A.H., Maehr, R., Fiebiger, E., Overkleeft, H.S., Rosemblatt,
M., Ploegh, H.L., and Lagaudriere-Gesbert, C. (2002). Analysis of protease activity in live
antigen-presenting cells shows regulation of the phagosomal proteolytic contents during
dendritic cell activation. J Exp Med 196, 529-540.
Lesterhuis, W.J., Haanen, J.B., and Punt, C.J. (2011). Cancer immunotherapy--revisited. Nat
Rev Drug Discov 10, 591-600.
Longhi, M.P., Trumpfheller, C., Idoyaga, J., Caskey, M., Matos, I., Kluger, C., Salazar, A.M.,
Colonna, M., and Steinman, R.M. (2009). Dendritic cells require a systemic type I interferon
response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med
206, 1589-1602.
Longman, R.S., Braun, D., Pellegrini, S., Rice, C.M., Darnell, R.B., and Albert, M.L. (2007).
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects
of IFN-alpha/beta on antigen cross-presentation. Blood 109, 1113-1122.
Lorenzi, S., Mattei, F., Sistigu, A., Bracci, L., Spadaro, F., Sanchez, M., Spada, M.,
Belardelli, F., Gabriele, L., and Schiavoni, G. (2011). Type I IFNs control antigen retention
and survival of CD8alpha(+) dendritic cells after uptake of tumor apoptotic cells leading to
cross-priming. J Immunol 186, 5142-5150.
Mahnke, K., Guo, M., Lee, S., Sepulveda, H., Swain, S.L., Nussenzweig, M., and Steinman,
R.M. (2000). The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance
antigen presentation via major histocompatibility complex class II-positive lysosomal
compartments. J Cell Biol 151, 673-684.
Maraskovsky, E., Schnurr, M., Wilson, N.S., Robson, N.C., Boyle, J., and Drane, D. (2009).
Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant.
Immunol Cell Biol 87, 371-376.
Marrack, P., Kappler, J., and Mitchell, T. (1999). Type I interferons keep activated T cells
alive. J Exp Med 189, 521-530.
Marrack, P., McKee, A.S., and Munks, M.W. (2009). Towards an understanding of the
adjuvant action of aluminium. Nat Rev Immunol 9, 287-293.
Marshall, H.D., Prince, A.L., Berg, L.J., and Welsh, R.M. (2010). IFN-alpha beta and self-
MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid
acquisition of effector functions. J Immunol 185, 1419-1428.
246